ClinVar Miner

Submissions for variant NM_000352.6(ABCC8):c.61del (p.Val21fs)

dbSNP: rs2133737961
Minimum review status: Collection method:
Minimum conflict level:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Natera, Inc. RCV006644789 SCV007533986 pathogenic Hereditary hyperinsulinism 2024-08-13 criteria provided, single submitter clinical testing The c.61delG variant in ABCC8 is a frameshift variant predicted to shift the reading frame beginning at codon 21 and leads to a stop codon 57 codons downstream. This variant is expected to result in nonsense mediated decay, truncation, or a dysfunctional protein product. This variant is rare in the general population with a frequency below the threshold expected for the associated phenotype(s). This variant has been observed in one or more individuals affected with the associated recessive disease, as either homozygous or compound heterozygous with a second variant (PMID: 34304300). Given the available evidence, this variant is classified as Pathogenic.
Neuberg Centre For Genomic Medicine, NCGM RCV002052035 SCV006333655 likely pathogenic Hyperinsulinemic hypoglycemia, familial, 1 criteria provided, single submitter clinical testing
Baylor Genetics RCV004572012 SCV005058574 pathogenic Type 2 diabetes mellitus 2024-03-28 criteria provided, single submitter clinical testing
Molecular Genetics, Madras Diabetes Research Foundation RCV002052035 SCV002318427 likely pathogenic Hyperinsulinemic hypoglycemia, familial, 1 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The submitted information has not been verified. If you have questions about the information contained on this website, please see a health care professional.